FDA NDC Directory · JSON-LD · Markdown

TYVASO

NDC 66302-206 · HUMAN PRESCRIPTION DRUG · INHALANT

Generic nametreprostinil
Labeler / ManufacturerUnited Therapeutics Corporation
Marketing categoryNew Drug Application (innovator) · App NDA022387
Dosage form / routeINHALANT · ORAL
Active ingredientsTREPROSTINIL (1.74 mg/2.9mL)
Marketing started20090814
Package count4

External sources

Source: openFDA. Public-domain (CC0).